In Vitro Protein Stability of Two Naturally Occurring Thiopurine S‑Methyltransferase Variants: Biophysical Characterization of TPMT*6 and TPMT*8

In Vitro Protein Stability of Two Naturally Occurring Thiopurine S‑Methyltransferase Variants: Biophysical Characterization of TPMT6 and TPMT8

Bibliographic Details
Main Authors:	Patricia Wennerstrand, Annica Blissing, Lars-Göran Mårtensson
Format:	Article
Language:	English
Published:	American Chemical Society 2017-08-01
Series:	ACS Omega
Online Access:	http://dx.doi.org/10.1021/acsomega.7b00801

Similar Items

Detection of Thiopurine S-Methyltransferase (TPMT) Polymorphisms TPMT*3A, TPMT*3B and TPMT*3C in Children with Acute Lymphoblastic Leukemia
by: Nawar S. Mohammed, et al.
Published: (2018-12-01)

Common Polymorphism’s Analysis of Thiopurine S-Methyltransferase (TPMT) in Iranian Population
by: Mehdi Azad, et al.
Published: (2009-01-01)

Positive TPMT genotype-phenotype correlation underscores importance of TPMT genotyping for personalized thiopurine dosing
by: Hui-min, Neoh, et al.
Published: (2012)

The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn’s Disease
by: Ha C, et al.
Published: (2020-11-01)

Thiopurine S-methyl Transferase (TPMT) Enzyme Level in Healthy Sudanese Population
by: Rayan Khalid, et al.
Published: (2024-09-01)

The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
by: Lennard, L, et al.
Published: (2010)

ASSOCIATION BETWEEN GENETIC VARIANTS IN TPMT AND NUDT15 AND THIOPURINE TOXICITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: A Nagel, et al.
Published: (2024-10-01)

Thiopurine methyltransferase (TPMT), nudix hydrolase 15 (NUDT-15) and methylene tetrahydrofolate reductase (MTHFR)polymorphisms in children with acute lymphoblastic leukaemia
by: Srikanth Marda, et al.
Published: (2022-01-01)

Homozygote CRIM1 variant is associated with thiopurine-induced neutropenia in leukemic patients with both wildtype NUDT15 and TPMT
by: Yoomi Park, et al.
Published: (2020-07-01)

TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned
by: Liuh Ling Goh, et al.
Published: (2022-09-01)

Thiopurines in the Management of Crohn’s Disease: Safety and Efficacy Profile in Patients with Normal TPMT Activity—A Retrospective Study
by: Amine Benmassaoud, et al.
Published: (2016-01-01)

Phenome-wide association studies on a quantitative trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics.
by: Antoine Neuraz, et al.
Published: (2013-01-01)

LC–MS/MS Method for Measurement of Thiopurine Nucleotides (TN) in Erythrocytes and Association of TN Concentrations With TPMT Enzyme Activity
by: Amol O. Bajaj, et al.
Published: (2022-03-01)

ITPA polymorphisms do not predict additional risk beyond TPMT and NUDT15 for thiopurine-induced cytopenia in inflammatory bowel disease
by: A. Jena, et al.
Published: (2024-01-01)

Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT
by: Hyery Kim, et al.
Published: (2021-05-01)

Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines.
by: Amit P Bhavsar, et al.
Published: (2017-01-01)

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency
by: Debbie S. Deben, et al.
Published: (2023-10-01)

Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution
by: Kelsey J. Cook, et al.
Published: (2023-08-01)

NUDT15 and TPMT polymorphisms in three distinct native populations of the Brazilian Amazon
by: Jamila Alessandra Perini, et al.
Published: (2024-02-01)

Population-Specific Distribution of TPMT Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine
by: Gallardo-Cóndor J, et al.
Published: (2023-11-01)

Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis
by: Qiang Miao, et al.
Published: (2021-04-01)

Variants in TPMT, ITPA, ABCC4 and ABCB1 genes as predictors of 6-mercaptopurine induced toxicity in children with acute lymphoblastic leukemia
by: Milošević Goran, et al.
Published: (2018-01-01)

Prevalence of TPMT and NUDT15 gene polymorphisms and their impact on morbidities and chemotherapy delay in the consolidation phase
by: S. Abhilasha, et al.
Published: (2024-01-01)

Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease.
by: Ji Hyeon Lee, et al.
Published: (2017-01-01)

Ancestry and TPMT-VNTR Polymorphism: Relationship with Hematological Toxicity in Uruguayan Patients with Acute Lymphoblastic Leukemia
by: Gabriela Burgueño-Rodríguez, et al.
Published: (2020-11-01)

Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
by: Hong Zhou, et al.
Published: (2018-05-01)

TPMT Genetic Variability and Its Association with Hematotoxicity in Indonesian Children with Acute Lymphoblastic Leukemia in Maintenance Therapy
by: Rosdiana DS, et al.
Published: (2021-02-01)

Effects of TPMT, NUDT15, and ITPA Genetic Variants on 6-Mercaptopurine Toxicity for Pediatric Patients With Acute Lymphoblastic Leukemia in Yunnan of China
by: Xiaoyan Mao, et al.
Published: (2021-10-01)

Individualized therapy: Role of thiopurine S-methyltransferase protein and genetic variants
by: Pavlović Sonja, et al.
Published: (2010-01-01)

A bioinformatics approach to the identification of novel deleterious mutations of human TPMT through validated screening and molecular dynamics
by: Sidharth Saxena, et al.
Published: (2022-11-01)

P044: Pharmacogenetic profile for NUDT15 and TPMT in a Peruvian population with pediatric acute lymphoblastic leukemia
by: Jeny Bazalar-Montoya, et al.
Published: (2023-01-01)

Association of TPMT (rs1800460) Gene Polymorphism with Childhood Acute Lymphoblastic Leukemia in a Population from Guilan, Iran
by: Mohammad Hedayati, et al.
Published: (2020-09-01)

Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia.
by: McLeod, H, et al.
Published: (1999)

ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
by: Borhan Moradveisi, et al.
Published: (2019-08-01)

Thiopurine S-Methyltransferase and Methylenetetrahydrofolate Reductase Polymorphisms in Leukemia
by: Serhan Küpeli
Published: (2015-05-01)

Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation
by: K. B. Mirzaev, et al.
Published: (2020-09-01)

Enhanced specificity of TPMT*2 genotyping using unidirectional wild-type and mutant allele-specific scorpion primers in a single tube.
by: Dong Chen, et al.
Published: (2014-01-01)

Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population
by: Hamza Ben Zeglam, et al.
Published: (2015-03-01)

Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients
by: Nashwa Eltantawy, et al.
Published: (2023-01-01)

Case Report: Multifocal EBV-Associated Diffuse Large B-Cell Lymphoma in a Patient With 6-MP Associated Lymphopenia With TPMT Deficiency
by: Lara Müller-Scholden, et al.
Published: (2022-05-01)